Giant cell tumor at the wrist: a review of 23 cases; [El bileginde dev hücreli tümör: yirmi üç olgunun incelenmesi.]

Simple item page
dc.contributor.authorOzalp T.
dc.contributor.authorYercan H.
dc.contributor.authorOkçu G.
dc.contributor.authorOzdemir O.
dc.contributor.authorCoşkunol E.
dc.date.accessioned2024-07-22T08:23:43Z
dc.date.available2024-07-22T08:23:43Z
dc.date.issued2006
dc.description.abstractOBJECTIVES: We evaluated patients who underwent surgical treatment for giant cell tumor of the wrist with regard to recurrence rates, factors influencing tumor recurrence, complications, and postoperative functional and emotional status of the patients. METHODS: The study included 23 patients (6 males, 17 females; mean age 31.6 years; range 12 to 74 years) who were treated surgically for giant cell tumor of the wrist. Grading, assessment of surgical margins, and functional evaluation were performed according to the Enneking's criteria. The effects of tumor volume, soft tissue extension, and selected surgical therapy on recurrence were investigated. Joint movements and stability, postoperative pain, presence of deformity, muscle strength, limitations in functional activities, and patient satisfaction were evaluated. The mean follow-up period was 6.7 years. RESULTS: Of all the patients, 69% had stage 2 and 23% had stage 3 tumors. There was no significant correlation between tumor volume and recurrence (p=0.22). Recurrences were observed in three (33%) of nine patients with soft tissue extension and in four (28.6%) of 14 patients without soft tissue extension. Recurrence rates were 33.3% in those who were treated by curettage alone (n=3), 50% with curettage and grafting (n=6), 50% with curettage and bone cement (n=2), and 16% in those who underwent wide excision (n=12). CONCLUSION: The most important factor influencing recurrence rate in giant cell tumors is the extent of surgical resection. At least marginal resection must be considered in patients with stage 2 and 3 lesions especially in cases with soft tissue extension. Adjunctive therapy should be added if curettage is considered.
dc.identifier.issn1017995X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19663
dc.language.isoTurkish
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectBone Neoplasms
dc.subjectChild
dc.subjectFemale
dc.subjectGiant Cell Tumor of Bone
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNeoplasm Recurrence, Local
dc.subjectNeoplasm Staging
dc.subjectOrthopedic Procedures
dc.subjectReconstructive Surgical Procedures
dc.subjectRecovery of Function
dc.subjectTreatment Outcome
dc.subjectWrist
dc.subjectadolescent
dc.subjectadult
dc.subjectaged
dc.subjectarticle
dc.subjectbone tumor
dc.subjectcancer staging
dc.subjectchild
dc.subjectconvalescence
dc.subjectevaluation
dc.subjectfemale
dc.subjecthuman
dc.subjectmale
dc.subjectmethodology
dc.subjectmiddle aged
dc.subjectorthopedic surgery
dc.subjectosteoclastoma
dc.subjectpathology
dc.subjectplastic surgery
dc.subjectradiography
dc.subjecttreatment outcome
dc.subjecttumor recurrence
dc.subjectwrist
dc.titleGiant cell tumor at the wrist: a review of 23 cases; [El bileginde dev hücreli tümör: yirmi üç olgunun incelenmesi.]
dc.typeArticle

Files

Collections

Scopus Koleksiyonu